| CAT No: | CL-GTM-06 |
| CAS No: | 52093-21-7 |
| Mol.F: | C20H41N5O7 |
| Mol.Wt.: | 463.6 |
| Chemical Name: | (2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4,6-Diamino-3-(((2R,3R,6S)-3-amino-6-((methylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diol |
| Inventory Status: | Custom synthesis |
This impurity is related to Gentamicin C2b is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Gentamicin C2b is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4,6-Diamino-3-(((2R,3R,6S)-3-amino-6-((methylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diolCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Gentamicin Molecular Formula: C20H41N5O7
Molecular Weight: 463.6
Storage: Store in a cool, dry place.
| Product Name: | Gentamicin C2b |
| CAS No: | 52093-21-7 |
| Mol.F.: | C20H41N5O7 |
| Mol.Wt.: | 463.6 |
Cat. No: CL-GTM-02
CAS No: 25876-10-2
Mol. F: C21H43N5O7
Mol. Wt: 477.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-03
CAS No: 26098-04-4
Mol. F: C19H39N5O7
Mol. Wt: 449.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-04
CAS No: 25876-11-3
Mol. F: C20H41N5O7
Mol. Wt: 463.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-05
CAS No: 59751-72-3
Mol. F: C20H41N5O7
Mol. Wt: 463.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-07
CAS No: NA
Mol. F: C19H37N5O7
Mol. Wt: 447.5
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-08
CAS No: 49751-51-1
Mol. F: C13H27N3O6
Mol. Wt: 321.4
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-09
CAS No: 36889-16-4
Mol. F: C20H40N4O10
Mol. Wt: 496.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-10
CAS No: NA
Mol. F: C19H39N5O9
Mol. Wt: 481.5
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-11
CAS No: 84107-26-6
Mol. F: C6H14N2O3 : 2(HBr)
Mol. Wt: 162.2 : 2(80.9)
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-NO-01
CAS No: NA
Mol. F: C21H42N6O8
Mol. Wt: 506.59
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-12
CAS No: NA
Mol. F: C13H27N3O6
Mol. Wt: 321.4
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-13
CAS No:
Mol. F: C21H43N5O8
Mol. Wt: 493.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-14
CAS No: NA
Mol. F: C21H43N5O8
Mol. Wt: 493.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-15
CAS No: NA
Mol. F: C21H41N5O7
Mol. Wt: 475.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-16
CAS No: NA
Mol. F: C21H41N5O7
Mol. Wt: 475.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-17
CAS No:
Mol. F: C21H41N5O7
Mol. Wt: 475.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-18
CAS No:
Mol. F: C21H41N5O8
Mol. Wt: 491.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-19
CAS No: NA
Mol. F: C21H41N5O8
Mol. Wt: 491.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-20
CAS No: NA
Mol. F: C21H41N5O8
Mol. Wt: 491.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-21
CAS No: NA
Mol. F: C21H41N5O8
Mol. Wt: 491.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-22
CAS No:
Mol. F: C21H41N5O9
Mol. Wt: 507.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-23
CAS No:
Mol. F: C21H41N5O9
Mol. Wt: 507.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-NO-02
CAS No: NA
Mol. F: C21H42N6O8
Mol. Wt: 506.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-NO-11
CAS No: NA
Mol. F: C21H42N6O9
Mol. Wt: 522.6
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-NO-12
CAS No: NA
Mol. F: C21H40N6O8
Mol. Wt: 504.59
Inv. Status: Custom Synthesis
Cat. No: CL-GTM-24
CAS No: 2037-48-1
Mol. F: C6H14N2O3
Mol. Wt: 162.2
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: